Nerve Growth Factor Activation of the TrkA Receptor Induces Cell Death, by Macropinocytosis, in Medulloblastoma Daoy Cells
Overview
Affiliations
Ectopic expression of the TrkA receptor tyrosine kinase in tumors of the nervous system can mediate nerve growth factor (NGF)-dependent cell death by apoptosis and /or autophagy. Herein, we demonstrate that TrkA can also induce cell death in medulloblastoma Daoy cells by a caspase-independent mechanism that involves the hyperstimulation of macropinocytosis. Specifically, NGF-stimulates the uptake of AlexaFluor546-dextran into lysosome-associated membrane protein-1 positive vacuoles which fuse with microtubule associated protein light chain 3 (LC3) positive autophagosomes, to form large intracellular vacuoles (> 1 mum), which then fuse with lysotracker positive lysosomes. While LC3 cleavage and the appearance of LC3 positive vacuoles suggest the induction of autophagy, siRNA reduced expression of four proteins essential to autophagy (beclin-1, Atg5, LC3 and Atg9) neither blocks NGF-induced vacuole formation nor cell death. TrkA activated cell death does not require p38, JNK or Erk1/2 kinases but does require activation of class III PI-3 kinase and is blocked by the casein kinase 1 (CK1) inhibitor, D4476. This inhibitor does not interfere with TrkA activation but does block NGF-dependent AlexaFluor546-dextran uptake and CK1 dependent phosphorylation of beta-catenin. Collectively, these data demonstrate that TrkA stimulates cell death by a novel mechanism involving CK1-dependent hyperstimulation of macropinocytosis.
Yang K, Wu J, Li S, Wang S, Zhang J, Wang Y Cell Death Discov. 2023; 9(1):404.
PMID: 37907480 PMC: 10618268. DOI: 10.1038/s41420-023-01685-7.
Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications.
Allen N, Chauhan R, Bates P, OToole M Nanomaterials (Basel). 2022; 12(21).
PMID: 36364644 PMC: 9653665. DOI: 10.3390/nano12213869.
The Role and Therapeutic Potential of Macropinocytosis in Cancer.
Qiu Z, Liu W, Zhu Q, Ke K, Zhu Q, Jin W Front Pharmacol. 2022; 13:919819.
PMID: 36046825 PMC: 9421435. DOI: 10.3389/fphar.2022.919819.
Alamudi S, Kimoto M, Hirao I RSC Med Chem. 2021; 12(10):1640-1649.
PMID: 34778766 PMC: 8528270. DOI: 10.1039/d1md00199j.
Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis.
Puccini J, Badgley M, Bar-Sagi D Trends Cancer. 2021; 8(1):54-64.
PMID: 34649835 PMC: 8702483. DOI: 10.1016/j.trecan.2021.09.004.